期刊文献+

丹参酮Ⅱ_A诱导白血病细胞凋亡过程中端粒酶活性的改变 被引量:16

Alteration of activities of telomerase in tanshinone Ⅱ_A inducing apoptosis of the leukemia cells
下载PDF
导出
摘要 目的观察丹参酮ⅡA(TanⅡA)对HL60,K562细胞端粒酶活性的抑制作用和对凋亡相关基因的影响,探讨丹参酮ⅡA对造血细胞的作用机理。方法以HL60,K562为靶细胞,应用细胞培养技术,流式细胞术,透射电镜观察TanⅡA对HL60,K562细胞的作用,利用PCRTRAP方法检测TanⅡA处理前后HL60,K562细胞端粒酶活性的改变。结果经05μg·mL-1TanⅡA作用6d后,HL60,K562细胞生长明显受到抑制,生长抑制率分别为756%和563%。经丹参酮诱导后,HL60,K562细胞发生凋亡,出现亚二倍体峰;同时显著下调HL60及K562细胞的cmyc,bcl2基因表达,上调cfos基因表达。HL60,K562细胞在TanⅡA作用后,端粒酶活性受到抑制,端粒酶活性抑制率分别为308%,508%。结论TanⅡA可明显抑制HL60和K562细胞的增殖和细胞端粒酶活性,并诱导细胞凋亡。 Objective: To investigate the effect of tanshinone Ⅱ_A on HL-60 and K562 cells apoptosis,and to assay the inhibition of the telome rase activities in the leukemia cell apoptosis induced by Tanshinone. Method: Using the techniques of cell culture in vitro,flow cytometry and PCR-TRAP observed the telomerase activities and apoptosis of HL-60 and K562 cells which treated by Tan Ⅱ_A. Result: 0.5 μg·mL^-1 Tan Ⅱ_A could obviously inhibit HL-60 and k562 cell lines growth(P<0.05), down-regulate c-myc, bcl-2 gene and up-regulate c-fos and p53 gene expression as well as induce leukemia cell apoptosis,the apoptotic rates of HL-60 and K562 cells were 11.8% and 21.8% respectively. The telomerase activities significant decreased, the inhibiting rates in HL-60 and K562 cells were 30.8% and 50.8% respectively. Conclusion: Tan Ⅱ_A could significantly inhibit the proliferation and telomerase activities of HL-60 and K562 cells and induce the leukemia cell apoptosis. [
出处 《中国中药杂志》 CAS CSCD 北大核心 2005年第3期207-211,共5页 China Journal of Chinese Materia Medica
基金 卫生部科研基金资助项目(961240)
关键词 HL-60 K562细胞 端粒酶活性 丹参酮ⅡA 诱导 改变 凋亡 二倍体 生长 利用 tanshinone Ⅱ_A leukemia cell line telomerase apoptosis
  • 相关文献

参考文献12

  • 1梁勇,羊裔明,袁淑兰.丹参酮药理作用及临床应用研究进展[J].中草药,2000,31(4):304-306. 被引量:264
  • 2李登举.端粒酶与细胞周期、细胞凋亡及癌基因的关系[J].国外医学(分子生物学分册),2001,23(2):86-88. 被引量:10
  • 3何冬梅,张洹.端粒酶基因反义核酸促进顺铂诱导白血病细胞凋亡[J].中华内科杂志,2001,40(10):654-656. 被引量:7
  • 4袁淑兰,宋毅,王修杰,张洁.丹参酮ⅡA抑制多种肿瘤细胞生长的体外实验研究[J].华西药学杂志,2003,18(5):327-329. 被引量:43
  • 5Aragona M, Maisano R, Panetta S, et al. Telomere length maintenance in aging and caicinogensis, Int J Oncol,2002,17:981.
  • 6Cerezo H, Kalthoff M, Schuermann B. Dual regulation of telomerase activity through c-myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci,2002, 115(6): 1305.
  • 7Fujimoto K,Takahashi M.Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.Biochem Biophys Res Commun,1997,241(3):775.
  • 8Akiyama M, Iwase S, Horiguchi-Yamada J. Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells. Cancer Lett, 1999,142(1):23.
  • 9Dimberg A, Bahram F, Karlberg I, et al. Retinoid acid-induced cell cycle arrest of human myeloid cell lines is associmed with sequstial down-regulation of c-myc and cyclin E and posttranscriptional up-regulation of p27^kip1. Blood,2002,96:2199.
  • 10Norman E, Sharplessl, Ronald A. et al. Telomeres, stem cells, senescence, and cancer. J Clin Invest, 2004,113:160.

二级参考文献42

共引文献318

同被引文献229

引证文献16

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部